GGrantIndex
← Search

Hyperhomocysteinemia/Thrombosis Risk--Inflammatory Bowel

$0M01FY2000RRNIH

Massachusetts General Hospital, Boston MA

Investigators

Linked publications & trials

Abstract

The specific aim of this study is to determine whether plasma hyperhomocysteinemia is a significant risk factor for thrombosis in patients with IBD. This will be accomplished by comparing the prevalence of hyperhomocysteinemia in IBD patients with a history of thrombotic events ("cases") to the prevalence of hyperhomocysteinemia among matched IBD patients without thrombotic events ("controls").

View original record on NIH RePORTER →